| 1 |
Machine and deep learning approaches for cancer drug repurposing. SEMINARS IN CANCER BIOLOGY. 2021 pdf |
| 2 |
Deep learning for drug repurposing: Methods, databases, and applications. WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE. 2022 |
| 3 |
How has artificial intelligence impacted COVID-19 drug repurposing and what lessons have we learned? EXPERT OPINION ON DRUG DISCOVERY. 2022 pdf |
| 4 |
A comprehensive review of artificial intelligence and network based approaches to drug repurposing in Covid-19. BIOMEDICINE & PHARMACOTHERAPY.2022 pdf |
| 5 |
New Insights Into Drug Repurposing for COVID-19 Using Deep Learning. IEEE TRANSACTIONS ON NEURAL NETWORKS AND LEARNING SYSTEMS. 2021 |
| 6 |
Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL.2022 pdf |
| 7 |
Artificial intelligence, machine learning, and drug repurposing in cancer. EXPERT OPINION ON DRUG DISCOVERY. 2021 pdf |
| 8 |
Applications of artificial intelligence in drug development using real-world data. DRUG DISCOVERY TODAY. 2021 pdf |
| 9 |
Structure-based drug repurposing: Traditional and advanced AI/ML-aided methods. DRUG DISCOVERY TODAY.2022 pdf |
| 10 |
A deep learning framework for drug repurposing via emulating clinical trials on real-world patient data. NATURE MACHINE INTELLIGENCE.2021
. |
| 11 |
Machine learning identifies candidates for drug repurposing in Alzheimer's disease. NATURE COMMUNICATIONS. 2021 pdf |
| 12 |
Prediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL. 2021 pdf |
| 13 |
Recent advances in drug repurposing using machine learning. CURRENT OPINION IN CHEMICAL BIOLOGY. 2021 pdf |
| 14 |
An Analytical Review of Computational Drug Repurposing. IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS. 2021 |
| 15 |
Drug repurposing for COVID-19: Approaches, challenges and promising candidates. PHARMACOLOGY & THERAPEUTICS. 2021 pdf |
| 16 |
GCMM: graph convolution network based on multimodal attention mechanism for drug repurposing. BMC BIOINFORMATICS. 2022 pdf |
| 17 |
Identification of SARS-CoV-2 main protease inhibitors from FDA-approved drugs by artificial intelligence-supported activity prediction system. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS . 2021 |
| 18 |
Using informative features in machine learning based method for COVID-19 drug repurposing. JOURNAL OF CHEMINFORMATICS. 2021 pdf |
| 19 |
DeepLPI: a novel deep learning-based model for protein-ligand interaction prediction for drug repurposing. SCIENTIFIC REPORTS. 2022 pdf |
| 20 |
A Study of Drug Repurposing to Identify SARS-CoV-2 Main Protease (3CLpro) Inhibitors. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022 pdf |
| 21 |
A review on drug repurposing applicable to COVID-19. BRIEFINGS IN BIOINFORMATICS. 2021 |
| 22 |
BETA: a comprehensive benchmark for computational drug-target prediction. BRIEFINGS IN BIOINFORMATICS. 2022 |
| 23 |
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease. ALZHEIMERS RESEARCH & THERAPY.2022 pdf |
| 24 |
Repurposing FDA-approved drugs as HIV-1 integrase inhibitors: an in silico investigation. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS. 2022 |
| 25 |
Deep learning in target prediction and drug repositioning: Recent advances and challenges. DRUG DISCOVERY TODAY. 2022 pdf |
| 26 |
Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2. COMPUTERS IN BIOLOGY AND MEDICINE2022 pdf |
| |
|
| |
|
| |
|
| |
|
